FDA Inspection 1276733 — Otsuka Pharmaceutical Development & Commercialization, Inc.
The FDA completed an inspection of Otsuka Pharmaceutical Development & Commercialization, Inc. on Jun 25, 2025 in Princeton, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jun 25, 2025
- Fiscal Year
- 2025
- Product Type
- Devices
- Project Area
- Postmarket Assurance: Devices
- Location
- Princeton, NJ (United States)